Identifying Non-Invasive Predictive Biomarkers of Immune Related Adverse Events Using High-Sensitivity Multiplexed NULISAseq Protein Assays

Join this 58-minute panel webinar featuring Dr. Jamie S. Lin, MD, FASN and Dr. Niyati Jhaveri, PhD as they explore the identification of non-invasive predictive biomarkers for immune-related adverse events through high-sensitivity multiplexed NULISAseq protein assays. Learn about cutting-edge biomarker discovery techniques and their applications in predicting immune-related complications in clinical settings. Discover how advanced protein assay technologies can provide valuable insights into patient safety and treatment outcomes. Participate in the live Q&A session to engage directly with the expert presenters and deepen your understanding of this critical area of immunology and personalized medicine research.